Page last updated: 2024-10-25

clenbuterol and Acute Confusional Senile Dementia

clenbuterol has been researched along with Acute Confusional Senile Dementia in 2 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Research Excerpts

ExcerptRelevanceReference
"As neurodegenerative disorder, Alzheimer's Disease (AD) is postulated to share a common molecular mechanism with glaucoma."1.72Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance. ( Hohberger, B; Lämmer, R; Mardin, C; Müller, J; Prüss, H; Wallukat, G, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hohberger, B1
Prüss, H1
Mardin, C1
Lämmer, R1
Müller, J1
Wallukat, G1
Yu, NN1
Wang, XX1
Yu, JT1
Wang, ND1
Lu, RC1
Miao, D1
Tian, Y1
Tan, L1

Other Studies

2 other studies available for clenbuterol and Acute Confusional Senile Dementia

ArticleYear
Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Adrenergic Agents; Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoantibodies; Clenbuterol; G

2022
Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.
    Brain research, 2010, Mar-04, Volume: 1317

    Topics: Acute Disease; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Ant

2010